The third volume in the Institute of Animal Health (IAH) Biology of Animal Infections Series, Bluetongue discusses one of the most economically important diseases of domesticated livestock. Affecting primarily sheep particularly the improved mutton and wool breeds, it is now endemic in Africa, India, the Middle and Far East, Australia and the Americas, and over the last six years has caused a series of outbreaks throughout the Mediterranean region and central Europe. Bluetongue represent a paradigm not only for the other orbiviruses (such as African horse sickness virus, which shares the same vector species) but also for other insect transmitted diseases, including those of humans.
- The only single definitive work that provides both historical and up to date data on the disease
- Describes the latest developments in epidemiological modelling, molecular epidemiology and vaccine development, as well as explaining the current global epidemiology of the disease
- Outlines the importance and possible mechanisms of overwintering, and the impact of global warming on the vectors and virus distribution
Inhaltsverzeichnis
1;Front Cover;1 2;Bluetongue;4 3;Copyright Page;5 4;Contents;6 5;Series Introduction;16 6;Preface;20 7;Acknowledgement;22 8;Chapter 1 Introduction;24 8.1;Background;24 8.2;Bluetongue, an emerging disease;25 9;Chapter 2 The history of bluetongue;30 9.1;Introduction;30 9.2;Geographical distribution;30 9.3;Host range;32 9.4;Aetiology;34 9.5;Transmission;36 9.6;Control;37 10;Chapter 3 Bluetongue virus, other orbiviruses and other reoviruses: Their relationships and taxonomy;46 10.1;Introduction;46 10.2;The genera of the family Reoviridae;51 10.3;The genus Orbivirus;52 10.4;Classification and differentiation of the Orbivirus species;53 10.5;The economically important orbiviruses;55 10.6;Emerging orbiviruses;58 10.7;Orbiviruses that can infect humans;59 10.8;Relationships with other reoviruses;60 10.9;Phylogenetic relationships of the orbivirus proteins;62 10.10;Phylogenetic relationships between the RNA- dependent RNA polymerase (Pol RdRP) of the different orbiviruses;66 10.11;Phylogenetic relationships based on the sub-core shell T2 protein of bluetongue virus and other orbiviruses;67 10.12;Dating divergence times for bluetongue virus and epizootic haemorrhagic disease virus serotypes;69 11;Chapter 4 Bluetongue virus replication and assembly;76 11.1;Introduction;76 11.2;Arrangement of proteins in the virus outer capsid and their role in virus entry;77 11.3;Functional dissection of the enzymatic core proteins;80 11.4;Assembly of the viral core;84 11.5;Assembly of the viral outer capsid;89 11.6;Release of progeny virions from infected cells;90 11.7;Concluding remarks;94 12;Chapter 5 Bluetongue virus: cell biology;100 12.1;Introduction;100 12.2;Bluetongue virus entry into the cellular host;101 12.3;Viral structures and their functions;104 12.4;Interaction of bluetongue virus with the cytoskeleton;110 12.5;Involvement of the cellular translation machinery during bluetongue virus infection;111 12.6;Fate of bluetongue virus-infected cells and virus egress;112 12.7;Conclusions
;117 13;Chapter 6 The structure of bluetongue virus core and proteins;124 13.1;Introduction;124 13.2;The bluetongue virion structure;125 13.3;Genome packaging;128 13.4;Enzyme functions and location;131 13.5;Substrate and product-binding sites;133 13.6;Binding of dsRNA to the bluetongue virus core surface;139 13.7;Bluetongue virus outer capsid proteins VP2 and VP5;143 13.8;Bluetongue virus non-structural proteins;144 13.9;Bluetongue virus particle structure and cell entry mechanisms;148 14;Chapter 7 Molecular epidemiology studies of bluetongue virus;158 14.1;Introduction;158 14.2;Variable and conserved genome segments;160 14.3;BTV incursions into Europe;169 14.4;Phylogenetic analyses of BTV core/non-structural proteins and identification of reassortants;178 14.5;Conclusions/Discussion;179 15;Chapter 8 Bluetongue in the Indian subcontinent;190 15.1;Introduction;190 15.2;Geographical distribution and seasonality;191 15.3;Clinical bluetongue in sheep;193 15.4;Serological prevalence of bluetongue in other animal species;199 15.5;Vectors;203 15.6;Bluetongue virus serotypes reported from Indian subcontinent;205 15.7;Diagnosis;207 15.8;Molecular epidemiology studies;209 15.9;Economic impact of bluetongue and control;210 15.10;Acknowledgments;212 16;Chapter 9 Current status of bluetongue virus in the Americas;220 16.1;Introduction;220 16.2;North America;221 16.3;Central America;228 16.4;South America;230 16.5;Virusvector Interactions;233 16.6;Summary;235 16.7;Acknowledgments;235 17;Chapter 10 Bluetongue viruses in Australasia and East Asia;246 17.1;Introduction;246 17.2;Major studies of bluetongue virus in the region;247 17.3;Bluetongue disease in Australasia and East Asia;248 17.4;Bluetongue virus serotypes isolated in the region;249 17.5;The bluetongue virus genotypes in the region;252 17.6;The known and suspected Culicoides spp vectors;253 17.7;Conclusions;253 18;Chapter 11 Bluetongue in Europe and the Mediterranean Basin;258 18.1;Introduction;258 18.2;Bluetongue virus in
the Mediterranean Basin, 19982005;259 18.3;Origins of the outbreaks;270 18.4;Vector species of Culicoides in Europe and the Mediterranean Basin;273 18.5;Bluetongue virus in Europe in 2006 and 2007;275 18.6;Mechanisms of overwintering;277 18.7;Summary;279 19;Chapter 12 Bluetongue virus in the mammalian host and the induced immune response;288 19.1;Introduction;288 19.2;Bluetongue virus infection of the ruminant host;289 19.3;Bluetongue virus replication in the ruminant host;290 19.4;Immune response;296 19.5;A potential bluetongue virus overwintering mechanism in the ruminant host;298 19.6;Conclusive remarks;300 20;Chapter 13 Clinical signs and pathology;308 20.1;Introduction;308 20.2;Clinical signs;309 20.3;The pathogenesis of bluetongue virus infection;311 20.4;Persistent bluetongue virus infection of cattle;313 20.5;Bluetongue in other animal species;314 21;Chapter 14 Bluetongue virus in the insect host;318 21.1;Introduction;318 21.2;Culicoides biting midges;319 21.3;Bluetongue virus;319 21.4;Vector species of Culicoides;320 21.5;Infection and replication of bluetongue virus in vector Culicoides;324 21.6;Bluetongue virus infection and susceptibility rates in vector species of Culicoides;326 21.7;Barriers to the infection, dissemination and transmission of arboviruses in insect vectors;328 21.8;A possible overwintering mechanism of bluetongue virus in vector Culicoides;330 21.9;Effects of temperature on arbovirus infection and transmission by insect vectors;332 21.10;Effect of temperature on bluetongue virus infection by vector Culicoides;332 21.11;Summary;335 22;Chapter 15 Rates of bluetongue virus transmission between Culicoides sonorensis and sheep;344 22.1;Introduction;344 22.2;Materials and methods;346 22.3;Results;350 22.4;Discussion;360 22.5;Acknowledgements;363 23;Chapter 16 Bluetongue virus and climate change;366 23.1;Introduction;366 23.2;The shifting pattern of European bluetongue epidemics;367 23.3;Evidence linking patterns in bluetongue to climate chan
ge;370 23.4;Extended distribution of the major Old World vector, C. imicola;373 23.5;Involvement of Palearctic vectors in bluetongue virus transmission in Europe;374 23.6;Why is the bluetongue virusCulicoides episystem responsive to climate change?;378 23.7;A global view of climate change and bluetongue epidemiology;379 23.8;Acknowledgements;381 24;Chapter 17 Bluetongue virus diagnosis;388 24.1;Introduction;388 24.2;Clinical diagnosis;392 24.3;Virus isolation;393 24.4;Antibody/antigen-based assays;394 24.5;Molecular assays;400 24.6;Detection of BTV in Culicoides midges;407 24.7;Ring-trials and proficiency testing;409 24.8;Diagnostic samples;410 24.9;The future;411 25;Chapter 18 Bluetongue virus vaccines past and present;420 25.1;Introduction;420 25.2;Multiple BTV serotypes;424 25.3;Attenuated 'live' vaccines;425 25.4;Live vaccine 'platforms';430 25.5;Inactivated BTV vaccines;431 25.6;Subunit vaccines;432 25.7;Differentiating infected from vaccinated animals;437 25.8;Adjuvants;440 25.9;Regulations and acceptability;442 25.10;Concluding remarks;443 26;Chapter 19 Bluetongue control strategies;452 26.1;Introduction;452 26.2;Risk factors;453 26.3;The BT virus;456 26.4;Methods of surveillance and monitoring;457 26.5;Modelling;461 26.6;Methods of control;461 26.7;Control strategies;464 26.8;International legislation;468 27;Chapter 20 Conclusions;476 28;Glossary;482 29;Index;488